Clinical Trial Update: Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's Disease

View source ↗

Summary

A post-marketing surveillance study sponsored by Boehringer Ingelheim in idiopathic Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Parkinson Disease | Status: COMPLETED